Featured Article
Category: News
LensART Laser System Receives FDA Clearance For Lens Fragmentation And Anterior Capsulotomy In Cataract Surgery
LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced today that the company has received 510(k) clearance from the FDA for use of the LensART Laser System for anterior capsulotomy and lens f…
Further Studies Needed To Assess Safety, Efficacy Of Superselective Ophthalmic Artery Chemotherapy
Superselective ophthalmic artery chemotherapy should be restricted to more advanced cases of retinoblastoma and should only be given in one eye, a study found.
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b…
LensART Laser System Receives FDA Clearance For Lens Fragmentation And Anterior Capsulotomy In Cataract Surgery
LensAR, Inc., the leading developer of next-generation laser technology for refractive cataract surgery, announced today that the company has received 510(k) clearance from the FDA for use of the LensART Laser System for anterior capsulotomy and lens f…
ISTA Pharmaceuticals Highlights BEPREVE(R) Clinical Data At The 2011 American Academy Of Allergy, Asthma And Immunology (AAAAI) Annual Meeting
ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA), today announced additional results from the Company’s BEPREVE(R) (bepotastine besilate ophthalmic solution) 1.5% Phase 3 clinical studies in allergic conjunctivitis. These results were presented in poster sess…
Omeros’ Ophthalmology Product OMS302 Achieves Co-Primary Endpoints In Phase 2b Clinical Study
Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today reported positive data from a Phase 2b…
Further Studies Needed To Assess Safety, Efficacy Of Superselective Ophthalmic Artery Chemotherapy
Superselective ophthalmic artery chemotherapy should be restricted to more advanced cases of retinoblastoma and should only be given in one eye, a study found.
Eyelid Surgery Boosts QOL in Facial Paralysis (CME/CE)
(MedPage Today) — For patients who couldn’t close their eyes because of facial paralysis, surgery produced a significant improvement in quality of life as well as in dryness and irritation, results of a small clinical study showed.
Diabetes Alert Day Raises Awareness Of ‘Silent Killer’ Diabetic Retinopathy
Diabetes is often called the “silent killer” because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately o…
Diabetes Alert Day Raises Awareness Of ‘Silent Killer’ Diabetic Retinopathy
Diabetes is often called the “silent killer” because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately o…
Diabetic Retinopathy Is The Leading Cause Of Blindness Among Working-Age Americans
Diabetes is often called the “silent killer” because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately o…
Diabetic Retinopathy Is The Leading Cause Of Blindness Among Working-Age Americans
Diabetes is often called the “silent killer” because people who have it are often unaware they are affected. According to the American Diabetes Association, diabetes affects 26 million people – including children – in the United States. Approximately o…
Nintendo 3DS to Help Identify Amblyopia and Other Vision Problems
Most kids, many pediatricians, and the occasional Medgadget editor would relish any opportunity to utilize video games to improve health. Microsoft’s Kinect sensor has been featured here on Medgadget numerous times for its medical applications in imagi…
Lower Initial Doses of IFN Effective for Behcet’s Uveitis
Starting with a low dose of interferon (IFN) for Behcet’s uveitis and raising it as necessary works just as well as higher-dose protocols, with fewer side effects, Turkish researchers say. Reuters Health Information
Nintendo 3DS to Help Identify Amblyopia and Other Vision Problems
Most kids, many pediatricians, and the occasional Medgadget editor would relish any opportunity to utilize video games to improve health. Microsoft’s Kinect sensor has been featured here on Medgadget numerous times for its medical applications in imaging and gesture controls. The Nintendo Wii was one of the first systems to exercise more than your fingers.
Ellex To Deliver New Diagnostic Ultrasound Mode At ASCRS
Adelaide, Australia, 23 March 2011 – Ellex Medical Lasers Limited (ASX:ELX), a global leader in ophthalmic laser and ultrasound technology, today announced that it will introduce a new diagnostic ultrasound mode for its leading Eye CubedT system at the…
Topcon To Release EyeRoute Synergy At Vision Expo East, New York
Oakland, New Jersey – March 18, 2011 – In addition to sponsoring continuing educational events at the Vision Expo and Conference in New York (March 16-20), Topcon will be releasing EyeRoute Synergy, the company announced today. Due to take place at Jac…
Perimetric Glaucoma Best Detected With OCT Through Average Peripapillary RNFL Thickness
The average thickness of the peripapillary retinal nerve fiber layer is the best optical coherence tomography parameter for determining perimetric glaucoma, a study found.
Topcon To Release EyeRoute Synergy At Vision Expo East, New York
Oakland, New Jersey – March 18, 2011 – In addition to sponsoring continuing educational events at the Vision Expo and Conference in New York (March 16-20), Topcon will be releasing EyeRoute Synergy, the company announced today. Due to take place at Jac…